Aditi Kare Panandikar is a third generation entrepreneur with sharp business acumen and techno-commercial skills. She is a graduate in Pharmacy, holds a Master’s Degree in Pharmaceutical Administration from the Ohio State University, USA. Patent Law and practices is another area in which she has pursued an in-depth study.
Aditi is the Managing Director at Indoco Remedies Limited, a fully integrated, research-oriented Indian Pharma Company with a strong global presence. The Company’s turnover is US$ 200 million with a human capital of 6000 employees, including over 300 skilled scientists and Field Staff who are the strength of the organization.
Indoco has 9 manufacturing facilities, 6 for Finished Dosages and 3 for APIs and is supported by a state-of-the-art R&D centre at Rabale, Navi Mumbai and a CRO at Hyderabad. The facilities have been approved by various regulatory authorities such as, as, USFDA, UK-MHRA, MOH Botswana, TGA-Australia, NMRA – Sri Lanka, FMHACA-Ethiopia, SUKL – Czech Republic, DPML- Ivory Coast, SAHPRA- South Africa, NDA-Uganda, MOH – Oman, INVIMA – Colombia, Health Canada, TFDA-Tanzania, MCA- Zimbabwe, MOHAP UAE, MOH-Yemen, NMPB
Sudan, OGYEI-Hungary, MOH-Ukraine, PPB-Kenya, NAFDAC – Nigeria, ZAMRA Zambia, MOPH- Qatar, NMRC -Namibia and FDA-Ghana.
Indoco has carved a place for itself in the international arena and is exporting a number of products in the Regulated and Emerging Markets. The Company has tie-ups with major generic companies and works in close coordination with its overseas customers for leveraging its core competencies.
Recently, Indoco acquired 85% of equity stake of the US based FPP Holding Company, LLC (“FPP Holding”) for USD 4 Million from Contract Pharmacal Corp. (“CPC”).
FPP Holding is the holding company of Florida Pharmaceutical Products, LLC (“FPP”) which is based in Florida and engaged in marketing and distribution of generic pharmaceutical products in the USA. This strategic investment marks a significant milestone for the Company, solidifying its position as a key player in the US market. The smart synergy between Indoco and FPP will enable the
Company to commercialize its registered generic products with a direct presence in the USA.
Prior to her elevation as Managing Director, Ms. Aditi has handled various functions like, Domestic Marketing – Formulations, API Business, HR, Technical (R&D & QA) and Business Development (International) at Indoco.
Ms. Aditi received the ‘Leader Of The Year’ award at the at the UBM India Pharma Awards in 2016, ‘Business Woman Of The Year’ award at the Business Goa Awards for Corporate Excellence 2016 and ‘Jack L. Beal Post baccalaureate Alumni’ award from the Ohio State University for her outstanding contribution to the pharma industry in May 2015.